1607010-81-0

Basic information

• Product Name: (2S,3R)-3-(3,5-dibenzyloxyphenoxy)-3-(3,5-dibenzyloxyphenyl)-propane-1,2-diol
• Synonyms: (2S,3R)-3-(3,5-dibenzyloxyphenoxy)-3-(3,5-dibenzyloxyphenyl)-propane-1,2-diol
• CAS NO: 1607010-81-0
• Molecular Weight: 668.786
• Mol File: 1607010-81-0.mol

Chemical Properties

• CAS DataBase Reference: (2S,3R)-3-(3,5-dibenzyloxyphenoxy)-3-(3,5-dibenzyloxyphenyl)-propane-1,2-diol(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3R)-3-(3,5-dibenzyloxyphenoxy)-3-(3,5-dibenzyloxyphenyl)-propane-1,2-diol(1607010-81-0)
• EPA Substance Registry System: (2S,3R)-3-(3,5-dibenzyloxyphenoxy)-3-(3,5-dibenzyloxyphenyl)-propane-1,2-diol(1607010-81-0)

Safety Data

• Hazardous Substances Data: 1607010-81-0(Hazardous Substances Data)

Upstream product

• 63604-98-8 1,3-dibenzylphloroglucinol 
• 1607010-78-5 (2S,3S)-3-(3,5-bis(benzyloxy)-phenyl)-oxiran-2-yl methanol 

Downstream Products

• 1607010-84-3 (S)-2-(R)-(3,5-bis(benzyloxy)-phenyl)-(3,5-dibenzyloxyphenoxy)-methyl oxirane 
• 1607010-87-6 (2R,3S)-5,7-bis(benzyloxy)-2-(3,5-bis(benzyloxy)phenyl)-3,4-dihydro-2H-1-benzopyran-3-ol 
• 1607010-90-1 (R)-5,7-bis(benzyloxy)-2-(3,5-bis(benzyloxy)phenyl)chroman-3-one 
• 863237-55-2 (2R,3R)-5,7-bis(benzyloxy)-2-(3,5-bis(benzyloxy)phenyl)chroman-3-ol 

Relevant articles and documents

Improved synthesis of structural analogues of (-)-epicatechin gallate for modulation of staphylococcal β-lactam resistance

The high-yielding synthesis of enantiomerically pure epicatechin gallate analogues where the A and/or B-ring hydroxylation is reduced or altered has been achieved by optimising routes to the catechin stereochemistry. The B-ring analogues were synthesised by using an electrophilic ring closure onto an enantiomerically enriched epoxide as a key step. The A and B-ring hydroxyl-deleted analogues were synthesised through a Mitsunobu cyclisation. For the B-ring analogues, the anti- (catechin) stereochemistry was converted to the syn- (epicatechin) stereochemistry by a known oxidation/reduction protocol. Absolute stereochemistry was derived from either a Sharpless epoxidation or asymmetric dihydroxylation.